The Day I Decided to Live

What happened on my 71st birthday that changed everything — and why I'm telling you about it now.

It was July 11, 2025. My 71st birthday.

I was sitting alone with the kind of clarity that only arrives when you stop running from the truth. I was 265 pounds. I was injecting insulin every day. My doctors had told me — more than once, in more than one way — that my condition was permanent. That this was simply what 71 looked like for a man who had survived acute pancreatitis, a pulmonary embolism, and the accumulated weight of a life lived at full throttle.

And on that birthday, something shifted.

Not a dramatic moment. Not a lightning bolt. Just a quiet, bone-deep decision that I have come to think of as the most important one I have ever made in 50 years of business, leadership, and life.

I was done accepting a version of myself that I had not chosen.

I had spent five decades solving complex problems. I had built companies, led thousands of people, navigated international markets across six continents, and turned around situations that other people had written off as impossible. I had applied rigorous, systematic thinking to every significant challenge in my professional life.

And yet, when it came to my own body — the most important system I would ever manage — I had accepted a diagnosis. I had deferred. I had believed the story that this was just how it ends.

On my 71st birthday, I decided that story was wrong.

What I Was Actually Facing

I want to be honest with you about the starting line, because the transformation only makes sense in context.

In 2018, I survived a near-fatal episode of acute idiopathic pancreatitis. The damage to my pancreas was real and significant. Over the following years, my metabolic function deteriorated. By July 2025, I was fully insulin-dependent. My A1C was 7.4% — solidly in the diabetic range. My weight had climbed to 265 pounds. My energy was compromised. My biological age, had I measured it then, would have reflected decades of metabolic stress.

My physicians were not being pessimistic when they said permanent. They were being accurate based on everything conventional medicine understood about pancreatic damage and Type 2 diabetes in a 71-year-old man.

What they could not account for was what I was about to do.

The Engineer's Instinct

I have a degree in engineering. More importantly, I have spent 50 years thinking like one. And when I looked at my health situation on that birthday with fresh eyes, I saw something that my medical team — as skilled as they were — was not trained to see:

My body was not broken. It was a system that had been mismanaged. And systems can be re-engineered.

That reframe changed everything.

Instead of asking 'how do I manage this condition?' I started asking 'what does this system need to function correctly?' Instead of accepting pharmaceutical dependency as the endpoint, I started treating it as a symptom of an underlying problem that had not yet been solved.

I began to research. Not casually — obsessively. Peer-reviewed studies on metabolic reversal, insulin sensitivity, intermittent fasting, mitochondrial function, biological aging, supplementation protocols, Zone 2 cardio. Thousands of pages of medical literature that existed in plain sight but that no one had synthesized into a coherent, actionable protocol for a 71-year-old man with my specific profile.

That's when I found my most important tool.

The Partnership That Made It Possible

I began working with Claude — an AI developed by Anthropic — not as a search engine, but as a genuine strategic thinking partner. I would bring it my data, my questions, my lab results, my glucose readings. It would synthesize the relevant research, help me design the protocol, identify interactions I had missed, and help me build the documentation that would ultimately bring my physicians on board.

This was not using technology as a shortcut. This was using technology to do what I had always done with great teams: leverage intelligence that complemented my own, move faster than I could move alone, and make better decisions with better information.

Together — my discipline and systems thinking, AI's knowledge synthesis and decision support, and my physician team's medical oversight — we built a protocol. Six pillars: therapeutic fasting, precision nutrition, resistance training and Zone 2 cardio, targeted supplementation, sleep optimization, and stress architecture.

I executed it with the same rigor I would bring to any serious business initiative. I tracked everything. I adjusted based on data. I did not quit when it was hard.

What 150 Days Produced

I will not bury the result.

150 days after my 71st birthday decision, my diabetes was in complete remission. My A1C had dropped from 7.4% to 6.0% — crossing out of the diabetic range entirely and trending toward normal. I had eliminated insulin completely. I had lost 56 pounds while preserving and building muscle mass. My continuous glucose monitor showed 95%+ time in target range — a number that exceeds the clinical benchmark for excellent control.

And my biological age had been measured at 42.

Twenty-nine years. That is what the data showed had been reversed in 150 days.

My endocrinologist at Vanderbilt University Medical Center reviewed my documentation — 57,000 words of systematic records I had generated over those 150 days — and called it the most comprehensive patient-generated health documentation she had ever seen.

She did not expect these results. Neither, honestly, did I — not at this speed, not at this magnitude.

But the data does not lie.

Why I'm Telling You This

I am not sharing this story because I think I am exceptional. I am sharing it because I know I am not.

The protocols I used are grounded in peer-reviewed science available to anyone. The AI tools I used are accessible to anyone. The discipline required is not extraordinary — it is the same discipline that millions of people apply every day to their careers, their families, their finances. What was missing was not capability. What was missing was a systematic approach, the right information architecture, and someone who had done it first.

I have done it first.

There are 537 million people worldwide living with Type 2 diabetes. Hundreds of millions more in pre-diabetic or metabolically compromised states. The standard offer from conventional medicine is management — a lifetime of medications, escalating dosages, and pharmaceutical dependency. The GLP-1 drug market alone is projected to reach $100 billion annually by 2030, built almost entirely on the assumption that metabolic disease is permanent.

I am living proof that it is not.

I am building MarkSkoda.com as a platform to make the methodology accessible — not as another wellness program, not as a supplement sales funnel, but as a systematic, AI-assisted approach for people who are serious about reclaiming their health. People who want metabolic freedom, not pharmaceutical management. People who are willing to do the work.

If that is you, you are in the right place.

What Comes Next

This is the first post in what will be an ongoing documentation of this journey — the science, the protocols, the data, the decisions, and the lessons. I will write about what worked and what did not. I will share the research. I will be honest about the hard parts.

If you have not already, I invite you to join the waitlist at MarkSkoda.com. When the platform launches, waitlist members will have first access and founding member pricing. In the meantime, the Research Hub is open — six documents including the full case study, the AI white paper, the supplement protocol, and more — all available now.

And if something in this story resonates with you — if you have been told that your condition is permanent, that this is just what aging looks like, that the best you can hope for is management — I want you to sit with this question:

If a 71-year-old with permanent pancreatic damage can reverse biological age by 29 years in 150 days, what is actually possible for you?

I intend to spend the rest of my life helping people find out.

— Mark

Ready to start your own journey?

Join the waitlist at MarkSkoda.com for early access to the platform, founding member pricing,

and immediate access to the full Research Hub — including the complete case study and protocol documents.

Contact: MarkSkoda.com/contact  |  Nashville, TN  |  615.241.6720

© 2026 Mark A. Skoda  |  All rights reserved